What's breaking now, across thousands of outlets.
Nearly half of drinkers who take GLP-1 medications have reported declines in consumption, with the effect higher among those at risk of unhealthy alcohol use, a new Harvard study shows. The work, published in the journal JAMA Psychiatry, explores an unexpected side effect of GLP-1s used to treat diabetes and obesity.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
Customers left wondering what's been compromised after vendor advises resetting passwords, 2FA and passkeys
A new report finds that countries around the world have committed to supporting sustainable fishing as a way to counter marine biodiversity loss, but urges them to strengthen accountability measures…
Full-disk encryption joins the toolkit, MATE and Xfce stay while Gershwin sits this one out
W.E.B. Du Bois' standing as a distinguished social scientist, with a distinguished body of work, has been subjected to the same marginalizing forces he examined in his pioneering scholarship on race…
If a dangerous asteroid were headed toward Earth, one defense could be a nuclear detonation to blast one side with X-rays and nudge it off course.
Some people carry antibodies that block the body's early defenses against viruses, increasing their risk of developing severe illnesses such as severe COVID-19.
